EU committee gives nod to Gilead's Viread for hepatitis B

03/20/2008 | Reuters

Gilead's HIV/AIDS drug Viread has been recommended for approval to treat hepatitis B by the European Medicines Agency's Committee for Medicinal Products for Human Use. The company is also awaiting approval from the FDA.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD